Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication
For instance, a study by Grace et al., on lambs receiving a single 2 mg subcutaneous B12 injection demonstrated significant increases in serum and liver B12 concentrations for up to 24 days compared to untreated animals (2)
The evidence base for tirzepatide as monotherapy is robust, with pivotal trials including SURMOUNT-1 demonstrating significant weight reduction in adults with obesity, and SURPASS trials establishing glycemic efficacy in type 2 diabetes
SAFETY AND RESEARCH Preclinical studies : Most of the research on BPC-157 has been conducted in animal models, showing promising results related to soft tissue integrity, as well as other system-specific support such as the gut-brain axis, the detoxification capabilities within the liver, and even neurotransmitter balance
Researchers should confirm that: No
US$ 27.14
US$ 20.45
US$ 29.62
US$ 27.46
US$ 28.61
